Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Oliver Bacon, MD, MPH

Title(s)Associate Clinical Professor, Medicine
SchoolSchool of Medicine
Phone628-206-2420
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Measuring the Quality of HIV/AIDS Care in Mexico
    NIH R03AI068550Aug 19, 2008 - Oct 31, 2011
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, Bacon O, Chege W, Coleman ME, Elion R, Buchbinder S, Kolber MA, Liu AY, Cohen SE. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV pre-exposure prophylaxis. AIDS. 2020 Mar 19. PMID: 32205724.
      View in: PubMed
    2. Spinelli MA, Glidden DV, Anderson PL, Gandhi M, Cohen S, Vittinghoff E, Coleman ME, Scott H, Bacon O, Elion R, Kolber MA, Buchbinder SP, Liu AY. Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing. J Acquir Immune Defic Syndr. 2019 06 01; 81(2):158-162. PMID: 31095005.
      View in: PubMed
    3. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 04 01; 33(5):825-832. PMID: 30882490.
      View in: PubMed
    4. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. PMID: 30503324.
      View in: PubMed
    5. Stephanie E Cohen, Darpun Sachdev, Sulggi Lee, Susan Scheer, Oliver Bacon, Miao-Jung Chen, Clarissa Ospina Norvell, Hideaki Okochi, Peter Anderson, Susa Coffey, Hyman Scott, Diane Havlir, Monica Gandhi. 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report. Open Forum Infectious Diseases. 2018 Nov 26; 5(suppl_1):s396-s397.
      View in: Publisher Site
    6. Doblecki-Lewis S, Liu AY, Feaster DJ, Cohen SE, Elion R, Bacon O, Coleman M, Cardenas G, Kolber MA. Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):62-69. PMID: 29771790.
      View in: PubMed
    7. Tang EC, Vittinghoff E, Anderson PL, Cohen SE, Doblecki-Lewis S, Bacon O, Coleman ME, Buchbinder SP, Chege W, Kolber MA, Elion R, Shlipak M, Liu AY. Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project. J Acquir Immune Defic Syndr. 2018 02 01; 77(2):193-198. PMID: 28991887.
      View in: PubMed
    8. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. PMID: 29112956.
      View in: PubMed
    9. Doblecki-Lewis S, Liu A, Feaster D, Cohen SE, Cardenas G, Bacon O, Andrew E, Kolber MA. Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017 04 15; 74(5):531-538. PMID: 27861236.
      View in: PubMed
    10. Bacon O, Gonzalez R, Andrew E, Potter MB, Iñiguez JR, Cohen SE, Liu AY, Fuchs JD. Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):175-179. PMID: 27654813.
      View in: PubMed
    11. Page K, Bacon O. Commitment issues: PrEP adherence in injecting drug users. Lancet HIV. 2017 02; 4(2):e52-e53. PMID: 27866872.
      View in: PubMed
    12. Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, Cohen SE. Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings. Curr HIV/AIDS Rep. 2016 Apr; 13(2):116-24. PMID: 26898645.
      View in: PubMed
    13. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med. 2016 Jan; 176(1):75-84. PMID: 26571482.
      View in: PubMed
    14. Cohen SE, Vittinghoff E, Doblecki-Lewis S, Coleman M, Bacon O, Elion R, Kolber MA, Buchbinder S, Liu AY. Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e33-5. PMID: 26049284.
      View in: PubMed
    15. SE Cohen, E Vittinghoff, SS Philip, S Doblecki-Lewis, O Bacon, W Chege, R Elion, S Buchbinder, MA Kolber, A Liu. 007.5 Sexual risk behaviour and sexually transmitted diseases among men who have sex with men participating in a pre-exposure prophylaxis demonstration project. Sexually Transmitted Infections. 2015 Sep 1; 91(Suppl 2):a41.2-a42.
      View in: Publisher Site
    16. Cohen SE, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle BS, Feaster DJ, Matheson T, Trainor N, Blue RW, Estrada Y, Coleman ME, Elion R, Castro JG, Chege W, Philip SS, Buchbinder S, Kolber MA, Liu AY. High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):439-48. PMID: 25501614.
      View in: PubMed
    17. Rose CD, Courtenay-Quirk C, Knight K, Shade SB, Vittinghoff E, Gomez C, Lum PJ, Bacon O, Colfax G. HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people. J Acquir Immune Defic Syndr. 2010 Dec 15; 55(5):572-81. PMID: 20827218.
      View in: PubMed
    18. Brentlinger PE, Assan A, Mudender F, Ghee AE, Vallejo Torres J, Martínez Martínez P, Bacon O, Bastos R, Manuel R, Ramirez Li L, McKinney C, Nelson LJ. Task shifting in Mozambique: cross-sectional evaluation of non-physician clinicians' performance in HIV/AIDS care. Hum Resour Health. 2010 Oct 12; 8:23. PMID: 20939909.
      View in: PubMed
    19. Patel P, Klausner JD, Bacon OM, Liska S, Taylor M, Gonzalez A, Kohn RP, Wong W, Harvey S, Kerndt PR, Holmberg SD. Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr. 2006 May; 42(1):75-9. PMID: 16763493.
      View in: PubMed
    20. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. PMID: 16565643.
      View in: PubMed